Firefly Neuroscience
AIFF
9 hedge funds and large institutions have $167K invested in Firefly Neuroscience in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.04% more ownership
Funds ownership: 1.3% → 1.34% (+0.04%)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
38% less capital invested
Capital invested by funds: $271K → $167K (-$103K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
+$49.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.62K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$5.08K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.25K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pathstone Holdings
Englewood,
New Jersey
|
-$86.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WPW
1
Waldron Private Wealth
Bridgeville,
Pennsylvania
| $62.1K | +$49.6K | +6,667 | +200% |
|
|
TWM
2
Trueblood Wealth Management
Lima,
Ohio
| $33.1K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $24K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $23K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $14.3K | +$9.62K | +1,293 | +127% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $6.5K | +$4.25K | +571 | +120% |
|
|
7
Wells Fargo
San Francisco,
California
| $4.26K | +$5.08K | +682 | +17,050% |
|
|
8
Bank of America
Charlotte,
North Carolina
| $25 | +$30 | +4 | New |
|
|
CA
9
Continuum Advisory
Eagle,
Idaho
| $2 | – | – | – |
|
|
10
Pathstone Holdings
Englewood,
New Jersey
| – | -$86.5K | -8,334 | Closed |
|
AIFF Hedge Fund Activity: Q2 2024 in Review
9 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q2 2024, worth a combined $167K — down 38% from $271K a quarter earlier.
Fund positioning in AIFF was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Waldron Private Wealth, adding an estimated $49.6K. The largest seller was Pathstone Holdings, exiting entirely with an estimated $86.5K sold.
- 9 institutional investors held Firefly Neuroscience (AIFF) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $167K of Firefly Neuroscience stock for Q2 2024, down 38% quarter-over-quarter.
- 1 fund opened new Firefly Neuroscience positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Firefly Neuroscience buyer in Q2 2024 was Waldron Private Wealth, an estimated $49.6K added.
- The largest Firefly Neuroscience seller in Q2 2024 was Pathstone Holdings, an estimated $86.5K sold.
Based on aggregated 13F filings for Q2 2024.